SCHEMBL2807604

SCHEMBL2807604

COCCCc1cc(C=O)ccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.41
PTGER4 P35408 1/20 0.40
ALDH1A1 P00352 11/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 3/20 0.37
HPGD P15428 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
AOX1 Q06278 1/20 0.37
TRIM24 O15164 1/20 0.37
ALDH5A1 P51649 1/20 0.37
ABAT P80404 1/20 0.37
TRIM33 Q9UPN9 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.36
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812857 0.95 FDPS (0.41) FDPSPTGER4ALDH1A1TSHRMAPT
SCHEMBL5959114 0.84 ALDH1A1 (0.39) FDPSALDH1A1TSHRMAPTHPGD
SCHEMBL9226581 0.81 ALDH1A3 (0.38) ALDH1A1TSHRCYP2D6CYP2C9
SCHEMBL2933054 0.78 FDPS (0.54) FDPSALDH1A1TSHRMAPTHPGD
SCHEMBL7120865 0.78 ALDH1A1 (0.40) FDPSPTGER4ALDH1A1TSHRMAPT
SCHEMBL27973305 0.76 CYP4F2 (0.49) ALDH1A1TSHRTDP1KMT2ACYP1A2
SCHEMBL7125837 0.75 CYP2A6 (0.44) FDPSPTGER4ALDH1A1TSHRMAPT
SCHEMBL2810557 0.75 KDM4E (0.41) ALDH1A1MAPTHPGDKMT2AL3MBTL1
SCHEMBL1444352 0.74 ALDH1A1 (0.50) FDPSPTGER4ALDH1A1TSHRMAPT
SCHEMBL13531116 0.73 ALDH1A1 (0.37) ALDH1A1TSHRMAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362040-B2 4-phenylpiperidine derivatives as renin inhibitors NOVARTIS AG (CH) 2013-01-29 US disclosed
US-20100240679-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors NOVARTIS AG (CH) 2010-09-23 US disclosed
EP-1689712-B1 4-PHENYLPIPERIDINE DERIVATIVES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-08-19 EP disclosed
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors SEDRANI RICHARD 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240679-A1 4-Phenylpiperidine Derivatives as Renin Inhibitors REN, AGTR1, ACE FDPS 520/4885PTGER4 932/4885ALDH1A1 466/4885
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors REN, AGTR1, ACE FDPS 520/4885PTGER4 932/4885ALDH1A1 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.